全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Critical Analysis of the Literature Comparing Artemisinin-Based Combination Therapy and Quinine Treatments for Uncomplicated Malaria in Pregnancy

DOI: 10.4236/oalib.1110938, PP. 1-8

Subject Areas: Clinical Medicine

Keywords: Artemisinin, Quinine, Comparison, Efficacy, Malaria, Pregnancy

Full-Text   Cite this paper   Add to My Lib

Abstract

In areas of high P. falciparum resistance, artemisinin derivatives and quinine are recommended as effective antimalarial drugs. In four randomized clinical trials, artemisinin- and quinine-based treatments (Quinine versus Artesunate-Atovaquone-Preguanil; Quinine versus Artesunate-Mefloquine; Quinine-Clindamycin versus Artesunate, Quinine versus Artemether-Lumefantrine) were compared to determine which regimen was more effective in treating uncomplicated malaria in pregnant women. It was not possible to make this choice as artemisinin derivatives in combination were compared with quinine alone and vice versa, as the WHO recommends dual therapy for the treatment of uncomplicated malaria in pregnant women. All regimens have been shown to be effective, with good tolerability and compliance, and less side-effects for artemisinin derivatives, and poor compliance and observance, as well as greater side-effects, for quinine. Balanced comparative studies will be useful in the future to settle this question.

Cite this paper

Nsonizau, D. M. P. , Kouzitissa, D. K. , Wasadidi, N. , Mazoba, T. K. and Damien, M. K. (2024). Critical Analysis of the Literature Comparing Artemisinin-Based Combination Therapy and Quinine Treatments for Uncomplicated Malaria in Pregnancy. Open Access Library Journal, 11, e938. doi: http://dx.doi.org/10.4236/oalib.1110938.

References

[1]  Mbanzulu Pita Nsonizau, D. (2022) Le paludisme de la femme enceinte sous les tropiques. Manuel de prise en charge, 2eme édition révisée et augmentée, CEPAS, 81p.
[2]  WHO Global Malaria (2013) Programme World Malaria Report 2013. World Health Organization, Geneva.
[3]  Worldwide Antimalarial Resistance Network (2023) De Nouvelles données pour optimiser le traitement du paludisme chez les femmes enceintes, Avril 2020. http://www.wwarn.org/fr
[4]  Ministère de la santé publique/PNLP/RDC. Le plan stratégique national de la lutte contre le paludisme 2020-2023.
[5]  Organisation Mondiale de la Santé (2021) Rapport mondial sur le paludisme 2021, Genève.
[6]  Saïto, M., Mansoor, R., Kennon, K., Anvikar, A.R., Ashley, E., Han, D.C., et al. (2020) Efficacité et tolérance des traitements à base d’artémisinine et à base de quinine pour le paludisme à falciparum non compliqué pendant la grossesse: une revue sytématique et une méta-analyse des données individuelles des patientes. Vol. 20, Elsevier. http://www.thelancet.com/infection
[7]  Achan, J., Talisuno, A.O., Arhart, A., Yeka, A., Tibenderana, J.K., Belleraine, F.N., et al. (2011) La quinine, un antipaludique ancien dans le monde moderne: rôle dans le traitement du paludisme. Malaria Journal, 10, 144. http://www.malariajournal.com/content/10/1/144
[8]  Mavoko, H.M., Nabasumba, C., da Luz, R.I., Tinto, H., D’Alessandro, U., Kambugu, A., et al. (2017) Efficacy and Safety of Re-Treatment with the Same Artemisinin-Based Combination Treatment (ACT) Compared with an Alternative ACT and Quinine plus Clindamycin after Failure of First-Line Recommended ACT (QUINACT): A Bicentre, Open-Label, Phase 3, Randomised Controlled Trial. The Lancet Global Health, 5, e60-e68. https://doi.org/10.1016/S2214-109X(16)30236-4 https://www.sciencedirect.com/science/article/pii/S2214109X16302364
[9]  Shayo, A., Buza, J. and Ishengoma, D.S. (2015) Monitoring of Efficacy and Safety of Artemisinin Based Anti-Malarials for Treatment of Uncomplicated Malaria: A Review of Evidence of Implementation of Anti-Malarial Therapeutic Efficacy Trials in Tanzania. Malaria Journal, 14, 135. https://doi.org/10.1186/s12936-015-0649-8
[10]  Ministère de la santé publique/RDC/PNLP (2013). Plan stratégique national de lutte contre le paludisme 2013-2015.
[11]  McGready, R., Ashley, E.A., Moo, E., Cho, T., Barends, M., Hutagalung, R., Looareesuwan, S., White, N.J. and Nosten, F. (2005) A Randomized Comparison of Artesunate-Atovaquone-Proguanil versus Quinine in Treatment for Uncomplicated Falciparum Malaria during Pregnancy. The Journal of Infectious Diseases, 192, 846-853. https://doi.org/10.1086/432551
[12]  McGready, R., Brockman, A., Cho, T., Cho, D., van Vugt, M., Luxemburger, C., Chongsuphajaisiddhi, T., White, N.J. and Nosten, F. (2000) Randomized Comparison of Mefloquine-Artesunate versus Quinine in the Treatment of Multidrug-Resistant Falciparum Malaria in Pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 689-693. https://doi.org/10.1016/S0035-9203(00)90235-9
[13]  McGready, R., Cho, T., Samuel, Villegas, L., Brockman, A., van Vugt, M., Looareesuwan, S., White, N.J. and Nosten, F. (2001) Randomized Comparison of Quinine-Clindamycin versus Artesunate in the Treatment of Falciparum Malaria in Pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 651-656. https://doi.org/10.1016/S0035-9203(01)90106-3
[14]  Piola, P., Nabasumba, C., Turyakira, E., Dhorda, M., Lindegardh, N., Nyehangane, D., Snounou, G., Ashley, E.A., McGready, R., Nosten, F. and Guerin, P.J. (2010) Efficacy and Safety of Artemether-Lumefantrine Compared with Quinine in Pregnant Women with Uncomplicated Plasmodium Falciparum Malaria: An Open-Label, Randomised, Non-Inferiority Trial. The Lancet Infectious Diseases, 10, 762-769. https://doi.org/10.1016/S1473-3099(10)70202-4

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413